ARCH Venture Fund XII, L.P.

3 filings 3 distinct issuers Active 2025-08-11 → 2026-10-26

Track Record

Total filings

1 SCHEDULE 13D · 1 SCHEDULE 13D/A · 1 SCHEDULE

Distinct issuers

100% issuer diversity

Median stake

18.23%

22,042,460 avg shares

AI briefs cached

0/3

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

+8.3%

across 2 filings · win rate 50%

Median 60d

-5.2%

across 2 filings · win rate 0%

Median 90d

-5.2%

across 2 filings · win rate 0%

Median 1y

—

across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 3 total

Filed	Form	Issuer	Stake	Shares
2026-10-26	SCHEDULE 13D	City Therapeutics, Inc.CTY	25.60%	13,692,507	view →
2026-04-01	SCHEDULE 13D/A	Neumora Therapeutics, Inc.NMRA	18.70%	33,847,838	view →
2025-08-11	SCHEDULE	Prime Medicine, Inc.PRME	10.40%	18,587,036	view →

Alert me when ARCH Venture Fund XII, L.P. files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →